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The members of Poxviridae family are among the most complex of animal viruses and subfamily members infect both
vertebrate (Chordopoxvirinae) and invertebrate (Entomopoxvirinae) hosts, respectively. Vaccinia virus (VV) is the most
commonly studied vertebrate virus and the entomopoxvirus of Amsacta moorei (AmEPV) is the prototypic insect virus.
AmEPV, while not able to productively infect vertebrate cells, does enter vertebrate cells and expresses early genes after
which the infection aborts although the cells survive (Y. Li, R. L. Hall, and R. W. Moyer. J.Virol. 71(12), 95579562, 1997). We show
here that a recombinant VV, containing the lacZ gene regulated by the cowpox virus A-type inclusion (ATI) late promoter,
likewise does not productively infect insect cells. Our results suggest that the recombinant VV enters insect cells, host
protein synthesis is inhibited, early gene expression is normal, and viral DNA replication occurs as does late protein
synthesis. However, little if any proteolytic processing of late viral proteins, typical of morphogenesis, is observed. Electron
micrographs of infected cells suggest that while cytoplasmic virosomes (factories) are formed, there is little indication of
further morphogenesis or any formation of mature virions. Therefore, while both orthopoxviruses and entomopoxviruses fail
to replicate in heterologous hosts, the nature of abortive infections is quite different. © 1998 Academic Press
INTRODUCTION
The Poxviridae family, comprises a large number of
complex DNA viruses which are characterized by a cy-
toplasmic site of replication. Poxviruses infect a variety of
vertebrate and invertebrate hosts and are subdivided
into two subfamilies, the Chordopoxvirinae (poxviruses
of vertebrates) and the Entomopoxvirinae (poxviruses of
insects).
Vaccinia virus (VV) is the most extensively studied
vertebrate poxvirus. The Entomopoxvirinae (EPV) were
only recently discovered (Vago, 1963) but are now known
to have a worldwide distribution and to productively
infect primarily the Orthoptera, Diptera, Coleoptera and
Lepidoptera orders of insects (Moyer, 1994; Arif, 1995).
The lepidopteran entomopoxvirus isolated from Amsacta
moorei (AmEPV) is the first insect poxvirus to be adapted
to grow in cultured insect cells (Granados, 1981; Good-
win et al., 1990; Dall et al., 1993) and is therefore one of
the best studied. More recently, a second EPV (Fernon et
al., 1995) from Heliothis armigera has also been adapted
to cell culture.
While VV and AmEPV share an overall biological strat-
egy and have some properties in common, there are also
some striking differences. Similarities include a similar
virion morphology, a large, linear, double-stranded DNA
genome (190 kb for VV, 225 kb for AmEPV), and common
sequence motifs which are associated with promoter
elements and nonspliced transcripts. There are also
some significant differences. For example, the genomes
of the two viruses differ widely in G 1 C content (37% for
VV, but only 18% for AmEPV), length of the replication
cycle, optimal growth temperature (37°C for VV, 26–28°C
for AmEPV), and most obviously host range (Moyer, 1994;
Arif, 1995). The limited serology available suggests that
there is little immunological relationship between the
two viruses.
A key consequence of the poxvirus replicative strategy
is that upon entry into cells, early viral genes are tran-
scribed by enzymes packaged within the infecting virion
core that are derived from viral proteins synthesized and
packaged from the infected cells of the previous growth
cycle. Following early gene expression and a second
step of uncoating, viral DNA replication ensues leading
to formation of cytoplasmic electron-dense virosomes or
‘‘factories’’ consisting of viral DNA. DNA replication is a
requirement for the initiation of intermediate and late
viral gene expression. In the case of VV, a series of
proteolytic events heralds the onset of morphogenesis
followed by virion assembly and concomitant packaging
of the early transcription apparatus necessary to initiate
the next round of infection.
Late in AmEPV infection, some virions typically be-
come embedded within a protein matrix forming large
cytoplasmic occlusion bodies or spheroids which con-
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sist primarily of a single protein, spheroidin (Bilimoria
and Arif, 1979; Langridge and Roberts, 1982; Hall and
Moyer, 1991; Banville et al., 1992). Spheroidin can com-
prise 30–40% of the protein of the infected insect cell.
Spheroidin is functionally similar to the highly expressed
A-type inclusion (ATI) protein of cowpox virus (CPV) (Pa-
tel et al., 1986; Funahashi et al., 1988) which can seques-
ter CPV within paracrystalline inclusions. This gene is
defective in VV (Amegadzie et al., 1992). Structurally, the
AmEPV spheroidin and CPV ATI gene promoters appear
to be quite similar, being AT rich and containing the
‘‘TAAATG’’ motif characteristic of a wide variety of verte-
brate poxvirus late promoters (Davison and Moss, 1989).
Despite these similarities, there is very little spheroidin
expression when the spheroidin gene is inserted into the
genome of either VV or CPV (Hall et al., 1996; Li et al.,
1998) suggesting that both the vertebrate and inverte-
brate viruses each have unique regulatory features.
Consistent with that prediction, we have recently
found that AmEPV infection of vertebrate cells leads to
an abortive infection. AmEPV enters vertebrate cells and
early, but not late genes are expressed (Li et al., 1997).
Similarly, when VV was used to infect BTI–EAA insect
cells, some viral protein synthesis was detected 10 h
after infection by enzyme-linked immunoadsorbent assay
(ELISA) using vaccinia virus antisera, indicating viral
entry into the insect cells. The protein(s) detected in
these very early studies were assumed to represent VV
structural proteins (Langridge, 1983a,b). VV DNA replica-
tion was not detected and the infection was assumed to
be abortive. The inability of EPVs to grow despite entry
into vertebrate cells and, similarly, the inability of vac-
cinia virus to grow in insect cells further emphasizes the
unique features of the two subfamilies of poxviruses.
We have more carefully examined the infection of
insect cells by VV. We show that VV viral DNA replication
occurs in VV-infected insect cells as does late gene
expression as indicated by b-galactosidase expression
from a lacZ reporter gene regulated by the CPV ATI late
gene promoter. Analysis of late viral proteins by pulse–
chase experiments gives no evidence of the proteolytic
processing of late proteins typical of viral morphogene-
sis necessary for a productive infection. While numerous
virosomes or ‘‘factories’’ were observed in VV-infected
insect cells, few assembly intermediates or virions were
noted, suggesting that impairment of morphogenesis ul-
timately leads to an abortive infection.
RESULTS
b-galactosidase expression in vaccinia recombinant
infected cells
Both AmEPV infection of vertebrate cells and VV infec-
tion of insect cells are generally accepted to be nonpro-
ductive. We have previously demonstrated that AmEPV-
infected vertebrate cells express only early viral genes
and that there is neither AmEPV viral DNA synthesis nor
expression of AmEPV late genes (Li et al., 1997). We
began our studies of VV infection of insect cells by first
analyzing infected cells for the expression of b-galacto-
sidase derived from either AmEPV or VV recombinant
viruses where the lacZ gene is regulated by the CPV ATI
gene promoter. Expression of b-galactosidase was
readily observed in both cases (Figs. 1C and 1D). No
b-galactosidase expression was seen in either mock-
infected cells or cells infected with wt AmEPV (Figs. 1A
and 1B). The proportion of stained cells in recombinant
VV-infected cells was dose dependent but the relative
efficiency noted for infection of insect cells at an m.o.i. of
10 (as determined in vertebrate cells) was only 15–20%
that of the vertebrate cells. We have found that a VV
multiplicity of 100 is needed to infect virtually all of the
insect cells.
The levels of b-galactosidase expressed by the VV
recombinants was also quantified and compared to
AmEPV lacZ recombinant viruses. Insect cells were in-
fected at an m.o.i. of 10 with AmEPV or 100 with VV
recombinant viruses each containing lacZ under control
of the CPV ATI promoter and allowed to adsorb for 2 h,
after which the media was removed and replaced with
fresh media with or without cytosine 1-b-D-arabino-
furanoside (AraC). At various times thereafter, cells were
harvested and the levels of b-galactosidase evaluated.
As shown in Fig. 2, in the absence of AraC, b-galactosi-
dase activity can be detected from either recombinant
virus by 12 h after infection with levels increasing until
48 h postinfection. The absolute level of AmEPV-medi-
ated b-galactosidase appears to be about twice that
from the VV recombinant, however, this difference may
still in part reflect incomplete infection of all the insect
cells by VV. The b-galactosidase expression is mediated
by late promoter activity as expected because in both
cases b-galactosidase expression was completely inhib-
ited by the addition of the AraC.
Analysis of viral DNA synthesis
The data of Figs. 1 and 2 show that VV infection of
insect cells results in late promoter regulated gene ex-
pression. During a VV infection, viral DNA replication is a
prerequisite for late viral gene expression and hence
unlike AmEPV-infected vertebrate cells, where the infec-
tion arrests prior to viral DNA synthesis, we would expect
VV viral DNA synthesis to occur in the infected insect
cells. Therefore, VV-infected insect cells were examined
for viral DNA synthesis (Fig. 3). As expected, VV viral
DNA synthesis is readily observed, first detectable by
12 h postinfection (Fig. 3B) consistent with the kinetics
observed for expression of late promoter regulated b-ga-
lactosidase. The time of induction of DNA synthesis was
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identical to that observed for AmEPV-infected insect
cells, but the levels of AmEPV DNA synthesis were con-
sistently higher despite the fact that the multiplicity of VV
used assured that virtually all the insect cells were in-
fected. It should be noted that the lacZ gene in VV is
located within the TK gene, rendering the virus TK neg-
ative. The AmEPV contains lacZ inserted within the
spheroidin gene. It is unlikely, however, that the lower
level of VV DNA synthesis is related to TK inactivation
because the LD cells used in these experiments contain
a functional TK gene (Hall et al., 1996; Li et al., 1997).
VV-infected insect cells fail to produce infectious
virus
Since both viral DNA synthesis and late gene expression
occur in VV-infected insect cells, we next determined
whether progeny virus was produced. Insect cells were
infected with either VV ATIlacZ or AmEPV ATIlacZ. Two
hours after addition of virus, the inoculum was removed,
fresh media added and the cells further incubated at 26°.
The infected cells were harvested at various times, the cells
disrupted to release any intracellular virus and titered. As
shown in Fig. 4, the production of AmEPV is readily detect-
FIG. 1. X-Gal staining of LD-652 cells infected with recombinant AmEPV ATI-LacZ or the recombinant VV ATI-LacZ. Cells were stained with X-Gal
48 h postinfection. (A) Mock-infected cells. (B) Wild-type AmEPV-infected cells at an m.o.i. of 10. (C) Recombinant AmEPV ATI-LacZ-infected cells at
an m.o.i. of 10. (D) Recombinant VV ATI-LacZ-infected cells at an m.o.i. of 100.
FIG. 2. Comparison of AmEPV- and VV- recombinant mediated-b–
galactosidase expression in LD-652 cells. Cells were infected with AmEPV
ATI-lacZ at an m.o.i. of 10 pfu/cell or VV ATI-lacZ at an m.o.i. of 100 pfu/cell.
After 2 h of incubation, the virus containing media was removed and
replaced with fresh medium. Infected cells were harvested at the times
indicated and extracts were prepared and assayed for b-galactosidase
activity. Each point represents the average of three independent assays of
AmEPV ATI-lacZ in the presence of AraC () or absence of AraC (f), and
of VV ATI-lacZ-infected cells in the presence of AraC (l) or in the absence
of AraC (l). O.D. 420, optical density at 420.
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able by 24 h postinfection and increases to about 72 h post
infection. No production of infectious VV was observed
despite the fact that both viral DNA and late protein syn-
thesis are observed, suggesting a defect in the assembly of
infectious virus. Attempts to rescue VV infection of insect
cells by co-infection with AmEPV were unsuccessful (data
not shown).
Electron microscopic examination of VV-infected
insect cells
Electron microscopic analysis of infected cells was
undertaken to determine whether VV-infected insect
cells are capable of forming any structures consistent
with viral assembly. Insect cells were infected with
either recombinant VV or AmEPV and at 48 h postin-
fection, cells were prepared for examination by elec-
tron microscopy (Fig. 5). In VV-infected insect cells,
cytoplasmic virosomes or ‘‘factories’’ were readily ob-
served (Fig. 5A) as on occasion were viral crescent-
like structures (Fig. 5B), but no spherical immature
particles nor mature virions were seen. Viral crescents
are one of the earliest structures associated with viral
morphogenesis. By contrast, mature virions were
readily visible in AmEPV infected cells (Figs. 5C and
5D). Characteristics of mature AmEPV virions include
the formation of a well-differentiated core (Fig. 5D).
Since the AmEPV ATIlacZ recombinant contains the
lacZ gene inserted within the spheroidin gene, the
resultant virus is spheroidin negative and no occlusion
body-related structures are observed.
Viral protein synthesis and processing in VV-infected
insect cells
It would appear that the block in the nonpermissive
VV infection of insect cells involves the late stages of
infection. Therefore, we next examined the patterns of
newly labeled viral proteins in VV-infected LD-652 and
CV-1 cells. Infected cells were pulse-labeled as de-
scribed (Winter et al., 1995) in Materials and Methods
at periods throughout the infection and the labeled
proteins then analyzed by SDS polyacrylamide gel
electrophoresis. The overall patterns of viral protein
synthesis in VV ATI-lacZ-infected insect and CV-1 cells
are similar (Fig. 6) and typical of the patterns expected
for late viral proteins. However, there also appears to
be generally less viral protein synthesis in the VV-
infected insect cells. The lower levels of late VV pro-
tein synthesis in the infected insect cells may reflect in
part the lower growth temperature (28°C) necessary
for the insect cells. Host protein synthesis is ultimately
inhibited in both cases which provides an indication
that VV has infected all the insect cells.
Proteolytic processing of late VV proteins is indicative
of viral morphogenesis. These proteolytic cleavages are
readily observed in vertebrate poxvirus-infected cells
when radiolabeled newly synthesized proteins are al-
lowed to incubate further after removal of the radiolabel.
Particularly noticeable, under such experimental condi-
tions is the processing of two major structural proteins of
VV, p4a and p4b, which are cleaved to mature forms of 63
and 60 kDa, respectively (Moss et al., 1969; Katz and
Moss, 1970a,b; Rosel and Moss, 1985; Van Meir and
Wittek, 1988; VanSlyke and Hruby, 1990). Therefore, to
evaluate protein processing of newly labeled proteins,
the labeled infected cells were further incubated in non-
radioactive media. Proteolytic processing of VV structural
FIG. 4. Titration of infectious VV ATI-lacZ in LD-652 cells. LD-652
cells were infected with recombinant VV ATI-lacZ at an m.o.i. of 100 or
AmEPV ATI-lacZ at an m.o.i. of 10. After 2 h of incubation, cells were
washed twice with serum-free medium and then fresh medium was
added. Cells and supernatants were harvested together at the times
indicated and sonicated. Cellular debris was removed by centrifuga-
tion. The clarified AmEPV (f)- and VV (l)-infected supernates were
then titered on LD-652 cells or CV-1 cells, respectively.
FIG. 3. Viral DNA synthesis in infected LD-652 insect cells. DNA
synthesis was examined in AmEPV ATI-lacZ- infected (m.o.i. 5 10) cells
(A) and VV ATI-lacZ-infected (m.o.i. 5 100) cells (B). Cells were infected,
the virus was removed after 2 h of absorption, and fresh medium was
added. Infected cells were harvested at the time indicated and viral
DNA was extracted. DNA synthesis was then measured by dot blot
analysis using a radiolabeled lacZ DNA probe as described in Mate-
rials and Methods. U, DNA from mock-infected cells.
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proteins was readily visible in VV infected control CV-1
cells at 8 and 24 h after labeling of the proteins (Fig. 7A)
but not in infected LD-652 cells (Fig. 7B). There is again
the question as to whether the failure to observe VV
protein proteolysis in infected cells is related to the lower
temperature (28°g) of infection. We have addressed this
question by analyzing VV protein proteolysis in both
VV-infected LD-652 and CV-1 cells at 32°C, an interme-
diate temperature for both cell lines. We found no differ-
ences from the data shown, i.e., Figs. 6 and 7 where
proteolysis is readily observed in infected CV-1 cells but
not infected insect cells. It is also interesting to note that
unlike VV late proteins, the processing of AmEPV late
viral proteins during a normal infection of LD-652 cells
has not been observed (Winter et al., 1995). The apparent
absence of the processing of late AmEPV proteins re-
flects a fundamental difference between the vertebrate
and insect poxviruses (Winter et al., 1995).
FIG. 5. Transmission electron microscopy of VV- or AmEPV-infected insect cells. VV ATI-lacZ-infected (A and B) and AmEPV ATI-lacZ-infected (C and
D) LD-652 cells at 48 h postinfection. (A) Arrowhead indicates newly replicated DNA of ‘‘virosomes’’ or ‘‘factories.’’ (B) Arrowhead shows bilayer
membrane ‘‘crescent’’ surrounding immature virions. (C) Arrowhead indicates mature AmEPV virion with a well-developed core. (D) Mature AmEPV
virions at somewhat higher magnification.
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DISCUSSION
We have previously shown that while AmEPV does not
productively infect vertebrate cells, the virus does enter
vertebrate cells and limited (early) viral gene expression
occurs. More specifically, expression of a lacZ reporter
gene was observed in recombinant AmEPV-infected ver-
tebrate cells if the lacZ gene was under control of either
of two entomopoxvius early gene promoters but not
when lacZ was regulated by either of two viral late
promoters (Li et al., 1997). Furthermore, no viral DNA
synthesis was observed in AmEPV-infected vertebrate
cells, and no reporter gene expression was observed if
the reporter gene was under control of late promoters (Li
et al., 1997). Therefore, the infection aborts after early
gene expression.
In contrast, the infection of insect cells by VV, while
also abortive, generates quite a different nonpermissive
phenotype in that the block appears to be quite late in
the infectious cycle. Expression of lacZ under control of
either a strong late vertebrate poxvirus (ATI) or AmEPV
(spheroidin) promoter is readily apparent (Figs. 1 and 2).
VV viral DNA synthesis was also observed within in-
fected insect cells (Fig. 3) but no virions are formed (Figs.
4 and 5). Although early studies (Langridge, 1983a,b)
showed some indications of viral protein synthesis in
VV-infected BTI-EAA insect cells early after infection,
there was no evidence of viral DNA synthesis (Lang-
ridge, 1983a,b).
Poxvirus gene expression is primarily regulated at the
level of transcription. During an infection, VV genes are
transcribed via a cascade mechanism comprising three
temporally distinct classes of mRNAs: early, intermedi-
ate, and late. Early genes are transcribed by enzymes
packaged within the virion. A subset of early proteins are
then able to act as transcription factors required for the
synthesis of intermediate genes and a subset of inter-
mediate genes serve as late gene transcription factors.
Both intermediate and late gene expression also depend
on viral DNA replication. Since we observe both viral
DNA replication (Fig. 3) and late promoter mediated
reporter gene expression (Figs. 1, and 2) as well as viral
late proteins (Figs. 6 and 7), it is safe to assume that both
early and intermediate VV gene expression is relatively
normal.
Labeling of newly synthesized VV proteins within in-
fected insect cells (Fig. 6), clearly suggests late genes
are expressed, however, no processing of late proteins is
observed (Fig. 7). Electron microscopic examination (Fig.
5) of infected cells suggests that few if any virions are
formed. DNA containing Virosomes (factories) are readily
observed, but no morphological structures normal asso-
ciated with viral assembly are observed with the excep-
tion of a few membrane ‘‘crescent,’’ structures thought to
be among the very earliest of intermediates associated
FIG. 6. Analysis of newly labeled proteins in VV-infected insect cells
and vertebrate cells. VV ATI-lacZ-infected CV-1 (A) and LD-652 (B) cells.
U, mock-infected cells and the times after infection (h) for the initiation
of the pulse-labeling of proteins are indicated. The arrow indicates the
position of b-galactosidase. Molecular weight size standards are indi-
cated on the left.
FIG. 7. Late protein processing in VV ATI-lacZ-infected CV-1 and
insect cells. CV-1 cells (A) or LD-652 cells (B) were infected with VV
ATI-lacZ at multiplicities of 10 and 100, respectively. Late proteins were
pulse labeled at 12 h postinfection as described in Fig. 6 and Materials
and Methods. The label was then removed, and the infected cells
further incubated for the periods of time indicated in the figure. The
samples were then harvested and analyzed by SDS-polyacrylamide gel
electrophoresis. Molecular weight size standards are indicated on the
left. U, mock-infected cells. In (A), the open arrows indicate the pro-
cessed, mature VV late 4a and 4b proteins. In (B), the closed arrow
shows the position of b-galactosidase.
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with viral morphogenesis (Fig. 5). We have attempted to
complement VV infections of insect cells by coinfection
with AmEPV to no avail.
What specific aspect of VV infection of insect cells is
defective? There are at least two possibilities. The first is
that the proteinase(s) responsible for processing of late
VV proteins in vertebrate cells is absent in insect cells.
The implication of this hypothesis is that the protein-
ase(s) is cellular in origin. A second possibility relates
directly to transcription. While VV protein synthesis ap-
pears relatively normal in infected insect cells, we do not
know that all VV promoters are recognized and utilized. It
has been shown that a components of both intermediate
(Rosales et al., 1994a,b) and late VV transcription factors
(Wright et al., 1998) are cellular in origin. It is possible
that the corresponding transcription factor subunits con-
tributed by the insect cells are either absent, nonfunc-
tional, or only partially able to function with the transcrip-
tional apparatus of the vertebrate VV.
Although the metabolic blocks in the two heterologous
sytems is clearly different, the fact that both viruses enter
their respective nonpermissive host cells suggests that
the cellular receptors that mediate binding and entry
have been relatively conserved. This is an interesting
observation considering that in general, unlike VV, ento-
mopoxviruses, do not generally grow in cultured cells.
Indeed, AmEPV is one of the few that has been adapted
to replicate in cultured insect cells (Granados, 1981;
Goodwin et al., 1990; Hukuhara et al., 1990; Marlow et al.,
1993; Fernon et al., 1995).
One of the most intriguing aspects of the AmEPV
abortive infection of vertebrate cells is that the limitation
of early gene expression can be reversed in part by
coinfection with VV (Li et al., 1997). Mixed infection of
vertebrate cells by both VV and AmEPV allows expres-
sion of reporter genes within the AmEPV genome regu-
lated by either the ATI or spheroidin late promoters.
Therefore, VV encodes a gene or genes which facilitate
further expression of the AmEPV genome in vertebrate
cells. Whether this gene(s) is related to direct facilitation
of transcription or perhaps to the uncoating of the virus
particle are but two of the most obvious possibilities
which are currently under investigation.
MATERIALS AND METHODS
Cells and virus
AmEPV (Hall and Moyer, 1991) was grown in IPLB-LD-
652 cells (Goodwin et al., 1990) maintained at 28°C in a
1:1 mixed medium (TE medium) of TC-100 media (Gibco,
Gaithersburg, MD) and EX-CELL 401 media (JRH Bio-
sciences, Lenexa, KS), supplemented with 10% fetal bo-
vine serum (FBS). Isolation of a thymidine kinase (TK)
negative TK (2) IPLB-LD-652 cell line, C11.3 has been
described earlier (Li et al., 1997). Vaccinia virus (VV) WR
strain (Condit and Motyczka, 1981) was grown at 37°C in
CV-1 cells, maintained in Eagle’s minimal essential me-
dia (MEM) with Earle’s salts supplemented with 5% FBS.
Rat TK (2) cells were maintained in MEM media con-
taining BUdR (100 mg/ml).
Construction and selection of recombinant viruses
pSPH-ATIlacZ and pVATIlacZ were constructed and
recombinants were selected as described previously
(Hall et al., 1996; Li et al., 1997, 1998). All inserts were
within the TK gene of the respective viruses or for
AmEPV, also within spheroidin (Hall et al., 1996). The
stable vaccinia recombinants were selected on rat TK
(2) cells in the presence of BUdR using standard tech-
niques (Smith and Moss, 1984). Virus titer was estimated
by plaque assay.
Assay of b-galactosidase, pulse-labeling and pulse–
chase of proteins in VV-infected CV-1 and LD 652
cells, and SDS–PAGE
IPLB-LD-652 cells (2 3 105 cell/well) or CV-1 cells (4 3
105) in 12-well plates were infected with recombinant
AmEPV at an m.o.i. of 10 pfu/cell or VV at an m.o.i. of 10
or 100 PFU/cell for CV-1 and IPLB-LD 652 cells, respec-
tively, for 2 h, unless stated otherwise. After 2 h, the
inoculum was removed, the cells were rinsed with se-
rum-free TE media or MEM media, and 1 ml of fresh
medium with or without cytosine 1-b-D-arabino-furano-
side (AraC) (200 ug/ml) was added to each well. At
appropriate times postinfection, the infected cells were
harvested by scraping into the media and freezing at
270° C until assayed. The b-galactosidase (b-gal) activ-
ity assays were performed using O-nitrophenyl-b-D-ga-
lactopyranoside (ONPG) as the substrate as described
previously (Miller, 1972). b-gal activity was measured at
420 nm of absorbance and normalized for OD420 per mg
of total protein (Bradford, 1976). The staining of b-galac-
tosidase in situ was performed 48 h after infection. The
infected cells were washed with PBS, fixed with a solu-
tion of 2% formaldehyde plus 0.2% glutaraldehyde pre-
pared in PBS and stained with a reaction mixture of
1 mg/ml 5-bromo-4-chloro-3-indolyl-b-D-galactosidase
(X-gal), 5 mM potassium ferricyanide, 5 mM potassium
ferrocyanide, and 2 mM magnesium chloride.
Pulse-labeling of newly synthesized proteins for 1-h
periods in either AmEPV- or VV-infected LD-652 insect
cells was performed as previously described (Winter et
al., 1995). LD-652 cells (2 3 105 cells/well) or CV-1 cells
(4 3 105 cells/well) in 12-well plates were infected with
VV ATI-lacZ at an m.o.i. of 100 or 10 pfu/cell, respectively,
and the virus adsorbed for 2 h. The inoculum was then
removed, the cells rinsed with serum-free media and
then incubated in regular media. Before labeling, the
cells of individual wells were washed with 1 ml of me-
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thionine-free EX-CELL 401 (JRH biosciences) or 1 ml of
methionine-free minimum essential Eagle’s medium
(Sigma) and incubated in these methionine-free media
for 45 min to deplete amino acid pools. The cells were
then incubated in 0.4 ml methionine-free EX-CELL me-
dium or minimum essential Eagle’s medium containing
60 mCi/ml Trans 35S-label (ICN Pharmaceuticals, Inc.,
Irvine, CA) and incubated for 1 h. The cells were then
washed with PBS to remove unincorporated label and
lysates prepared for analysis via protein electrophoresis.
To evaluate proteolytic processing of late proteins, the
radioactive medium was removed after the 1-h labeling
period from the cells and replaced with regular media.
The cells were then further incubated for additional pe-
riods of time as indicated. Harvest of samples and anal-
ysis of the radiolabeled proteins by electrophoresis
through 10% SDS-polyacrylamide gels was as previously
described (Hall and Moyer, 1991).
Estimation of viral DNA synthesis by dot blot analysis
Viral DNA synthesis in infected cells was estimated
using dot blot analysis as described previously (Li et
al., 1997).
Electron microscopy
Cells were infected with either recombinant AmEPV or
VV and harvested at 48 h postinfection. The infected cells
were harvested by scraping into the medium and col-
lected by centrifugation at 500 g for 5 min. The samples
were treated, sectioned and analyzed as described pre-
viously (Winter et al., 1995).
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